Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Colinz Laboratories Ltd is engaged in the manufacturing and marketing of pharmaceutical formulations.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
COLINZ LABORATORIES LTD. - 531210 - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements, Regulation 2015). | Download
COLINZ LABORATORIES LTD. - 531210 - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements, Regulation 2015). | Download
COLINZ LABORATORIES LTD. - 531210 - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue, Rights Issue, Preferential Issue, QIP) For The Quarter Ended 30.09.2024. | Download
COLINZ LABORATORIES LTD. - 531210 - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue, Rights Issue, Preferential Issue, QIP) For The Quarter Ended 30.09.2024. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant